Persistent lymphocytic leukemia (CLL) is actually a lymphoid malignancy characterised by the proliferation and accumulation of experienced CD5+ B cells in the blood, bone marrow and lymphoid tissues. The analysis of CLL requires the existence of ≥5 x109/L mono - clonal B cells of usual phenotype